Widespread deregulation of microRNA expression in human prostate cancer - PubMed (original) (raw)
Comparative Study
. 2008 Mar 13;27(12):1788-93.
doi: 10.1038/sj.onc.1210809. Epub 2007 Sep 24.
Affiliations
- PMID: 17891175
- DOI: 10.1038/sj.onc.1210809
Comparative Study
Widespread deregulation of microRNA expression in human prostate cancer
M Ozen et al. Oncogene. 2008.
Abstract
MicroRNAs (miRNAs) are small regulatory RNAs that can regulate gene expression by binding to mRNA sequences and repressing target-gene expression post-transcriptionally, either by inhibiting translation or promoting RNA degradation. We have analysed expression of 328 known and 152 novel human miRNAs in 10 benign peripheral zone tissues and 16 prostate cancer tissues using microarrays and found widespread, but not universal, downregulation of miRNAs in clinically localized prostate cancer relative to benign peripheral zone tissue. These findings have been verified by real-time RT-PCR assays on select miRNAs, including miR-125b, miR-145 and let-7c. The downregulated miRNAs include several with proven target mRNAs whose proteins have been previously shown to be increased in prostate cancer by immunohistochemistry, including RAS, E2F3, BCL-2 and MCL-1. Using a bioinformatics approach, we have identified additional potential mRNA targets of one of the miRNAs, (miR-125b) that are upregulated in prostate cancer and confirmed increased expression of one of these targets, EIF4EBP1, in prostate cancer tissues. Our findings indicate that changes in miRNA expression may have an important role in the biology of human prostate cancer.
Similar articles
- The microRNA profile of prostate carcinoma obtained by deep sequencing.
Szczyrba J, Löprich E, Wach S, Jung V, Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A, Wullich B, Grässer F. Szczyrba J, et al. Mol Cancer Res. 2010 Apr;8(4):529-38. doi: 10.1158/1541-7786.MCR-09-0443. Epub 2010 Mar 30. Mol Cancer Res. 2010. PMID: 20353999 - MicroRNA expression profiling in prostate cancer.
Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. Porkka KP, et al. Cancer Res. 2007 Jul 1;67(13):6130-5. doi: 10.1158/0008-5472.CAN-07-0533. Cancer Res. 2007. PMID: 17616669 - Role of microRNAs in drug-resistant ovarian cancer cells.
Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. Sorrentino A, et al. Gynecol Oncol. 2008 Dec;111(3):478-86. doi: 10.1016/j.ygyno.2008.08.017. Epub 2008 Sep 26. Gynecol Oncol. 2008. PMID: 18823650 - MicroRNAs: small but potent oncogenes or tumor suppressors.
Lee YS, Dutta A. Lee YS, et al. Curr Opin Investig Drugs. 2006 Jun;7(6):560-4. Curr Opin Investig Drugs. 2006. PMID: 16784027 Review. - MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM, Green AR, Powe DG, Ellis IO. Khoshnaw SM, et al. J Clin Pathol. 2009 May;62(5):422-8. doi: 10.1136/jcp.2008.060681. J Clin Pathol. 2009. PMID: 19398594 Review.
Cited by
- The ribonuclease DIS3 promotes let-7 miRNA maturation by degrading the pluripotency factor LIN28B mRNA.
Segalla S, Pivetti S, Todoerti K, Chudzik MA, Giuliani EC, Lazzaro F, Volta V, Lazarevic D, Musco G, Muzi-Falconi M, Neri A, Biffo S, Tonon G. Segalla S, et al. Nucleic Acids Res. 2015 May 26;43(10):5182-93. doi: 10.1093/nar/gkv387. Epub 2015 Apr 29. Nucleic Acids Res. 2015. PMID: 25925570 Free PMC article. - MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.
Nadiminty N, Tummala R, Lou W, Zhu Y, Shi XB, Zou JX, Chen H, Zhang J, Chen X, Luo J, deVere White RW, Kung HJ, Evans CP, Gao AC. Nadiminty N, et al. PLoS One. 2012;7(3):e32832. doi: 10.1371/journal.pone.0032832. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479342 Free PMC article. - Identification of novel AR-targeted microRNAs mediating androgen signalling through critical pathways to regulate cell viability in prostate cancer.
Mo W, Zhang J, Li X, Meng D, Gao Y, Yang S, Wan X, Zhou C, Guo F, Huang Y, Amente S, Avvedimento EV, Xie Y, Li Y. Mo W, et al. PLoS One. 2013;8(2):e56592. doi: 10.1371/journal.pone.0056592. Epub 2013 Feb 22. PLoS One. 2013. PMID: 23451058 Free PMC article. - WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
Tabatabaeian H, Lim SK, Chu T, Seah SH, Lim YP. Tabatabaeian H, et al. Life Sci Alliance. 2021 Jun 11;4(7):e202101038. doi: 10.26508/lsa.202101038. Print 2021 Jul. Life Sci Alliance. 2021. PMID: 34117091 Free PMC article. - miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer.
Sacconi A, Biagioni F, Canu V, Mori F, Di Benedetto A, Lorenzon L, Ercolani C, Di Agostino S, Cambria AM, Germoni S, Grasso G, Blandino R, Panebianco V, Ziparo V, Federici O, Muti P, Strano S, Carboni F, Mottolese M, Diodoro M, Pescarmona E, Garofalo A, Blandino G. Sacconi A, et al. Cell Death Dis. 2012 Nov 15;3(11):e423. doi: 10.1038/cddis.2012.160. Cell Death Dis. 2012. PMID: 23152059 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical